Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
11
×
Tags
drugs
11
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
boston
fda
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
alnylam pharmaceuticals
biotech
san francisco blog main
san francisco top stories
patisiran
rna interference
akcea therapeutics
aminolevulinic acid
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
givosiran
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
merck
national
onpattro
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
tafamidis
texas top stories
wisconsin blog main
What
medicine
11
×
fda
drug
alnylam
new
rna
ago
approved
cells
data
interference
pharmaceuticals
rnai
second
cleared
clinical
gene
market
oks
seek
speedy
time
uses
weeks
adapt
aldeyra
allergan
approval
approve
approves
awaits
battle
biological
blessing
bosley
brexanolone
cancer
cannabis
cellular
ceo
Language
unset
Current search:
xconomy.com
×
medicine
×
photo
×
drugs
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing